椎间盘退变的生物治疗研究进展
Advances in the Biological Therapies of Intervertebral Disc Degeneration
摘要: 文章系统综述椎间盘退变(Intervertebral Disc Degeneration,以下简称IDD)的生物治疗研究进展。IDD作为一种常见的退行性疾病,严重影响患者生活质量并带来社会经济负担。传统治疗方法虽可缓解症状,却难以逆转退变进程。近年来,生物治疗策略展现出显著潜力,包括小分子化合物治疗(抗炎、抗氧化、调控代谢等)、细胞疗法(如间充质干细胞移植)、基因治疗(靶向基因编辑与调控)和组织工程(生物活性支架与再生医学策略)等,为椎间盘再生修复提供了新方向。然而,这些新型治疗手段仍面临药物稳定性、干细胞存活与安全性、载体效率及材料生物相容性等多重挑战。未来研究应注重多学科交叉融合、中西医结合和个体化治疗,以推动IDD生物治疗技术的临床转化与应用。
Abstract: This systematic review summarizes the pathological mechanisms and advances in biological therapies for intervertebral disc degeneration (IDD). As a prevalent degenerative disorder, IDD severely compromises patients’ quality of life and imposes substantial socioeconomic burdens. Conventional treatments only palliate symptoms without reversing the degenerative cascade. Recently, biological strategies—including small-molecule agents (anti-inflammatory, antioxidant and metabolic modulators), cell-based therapies (e.g., mesenchymal stem-cell transplantation), gene therapy (targeted editing and regulation) and tissue engineering (bioactive scaffolds and regenerative strategies)—have shown remarkable promise for disc regeneration, providing a new direction for intervertebral disc regeneration and repair. Nevertheless, clinical translation is still hindered by challenges such as drug stability, stem-cell survival and safety, vector efficiency and biomaterial biocompatibility. Future research should emphasize interdisciplinary integration, the synergy of traditional Chinese and Western medicine, and individualized therapy to accelerate the clinical application of IDD biological interventions.
文章引用:林可心, 李若烟, 樊效鸿. 椎间盘退变的生物治疗研究进展[J]. 临床医学进展, 2025, 15(10): 1000-1009. https://doi.org/10.12677/acm.2025.15102848

参考文献

[1] Knezevic, N.N., Candido, K.D., Vlaeyen, J.W.S., Van Zundert, J. and Cohen, S.P. (2021) Low Back Pain. The Lancet, 398, 78-92. [Google Scholar] [CrossRef] [PubMed]
[2] Hartvigsen, J., Hancock, M.J., Kongsted, A., Louw, Q., Ferreira, M.L., Genevay, S., et al. (2018) What Low Back Pain Is and Why We Need to Pay Attention. The Lancet, 391, 2356-2367. [Google Scholar] [CrossRef] [PubMed]
[3] Aikenmu, K., Wang, Z. and Meng, Q. (2020) Comprehensive Multi-Factors Reveal the Pathogenesis of Degenerative Intervertebral Disc. Cellular and Molecular Biology, 66, 65-71. [Google Scholar] [CrossRef
[4] Liu, H., Kang, H., Song, C., Lei, Z., Li, L., Guo, J., et al. (2018) Urolithin a Inhibits the Catabolic Effect of TNFα on Nucleus Pulposus Cell and Alleviates Intervertebral Disc Degeneration in Vivo. Frontiers in Pharmacology, 9, Article No. 1043. [Google Scholar] [CrossRef] [PubMed]
[5] Li, P., Hou, G., Zhang, R., Gan, Y., Xu, Y., Song, L., et al. (2017) High-Magnitude Compression Accelerates the Premature Senescence of Nucleus Pulposus Cells via the P38 MAPK-ROS Pathway. Arthritis Research & Therapy, 19, Article No. 209. [Google Scholar] [CrossRef] [PubMed]
[6] Mohanty, S., Pinelli, R., Pricop, P., Albert, T.J. and Dahia, C.L. (2019) Chondrocyte‐Like Nested Cells in the Aged Intervertebral Disc Are Late‐Stage Nucleus Pulposus Cells. Aging Cell, 18, e13006. [Google Scholar] [CrossRef] [PubMed]
[7] Nishida, K., Kang, J.D., Gilbertson, L.G., Moon, S., Suh, J., Vogt, M.T., et al. (1999) 1999 Volvo Award Winner in Basic Science Studies: An in Vivo Study of Adenovirus-Mediated Transfer of the Human Transforming Growth Factor Beta 1 Encoding Gene. Spine, 24, 2419-2425. [Google Scholar] [CrossRef] [PubMed]
[8] Boos, N., Weissbach, S., Rohrbach, H., Weiler, C., Spratt, K.F. and Nerlich, A.G. (2002) Classification of Age-Related Changes in Lumbar Intervertebral Discs: 2002 Volvo Award in Basic Science. Spine, 27, 2631-2644. [Google Scholar] [CrossRef] [PubMed]
[9] Cheung, K.M.C., Karppinen, J., Chan, D., Ho, D.W.H., Song, Y., Sham, P., et al. (2009) Prevalence and Pattern of Lumbar Magnetic Resonance Imaging Changes in a Population Study of One Thousand Forty-Three Individuals. Spine, 34, 934-940. [Google Scholar] [CrossRef] [PubMed]
[10] Yurube, T., Ito, M., Kakiuchi, Y., Kuroda, R. and Kakutani, K. (2020) Autophagy and mTOR Signaling during Intervertebral Disc Aging and Degeneration. JOR SPINE, 3, e1082. [Google Scholar] [CrossRef] [PubMed]
[11] 周清, 阮狄克. 间充质干细胞修复椎间盘退变的研究进展[J]. 中国脊柱脊髓杂志, 2022, 32(6): 547-552.
[12] Kamali, A., Ziadlou, R., Lang, G., Pfannkuche, J., Cui, S., Li, Z., et al. (2021) Small Molecule-Based Treatment Approaches for Intervertebral Disc Degeneration: Current Options and Future Directions. Theranostics, 11, 27-47. [Google Scholar] [CrossRef] [PubMed]
[13] Lin, J., Chen, J., Zhang, Z., Xu, T., Shao, Z., Wang, X., et al. (2019) Luteoloside Inhibits Il-1β-Induced Apoptosis and Catabolism in Nucleus Pulposus Cells and Ameliorates Intervertebral Disk Degeneration. Frontiers in Pharmacology, 10, Article ID: 868. [Google Scholar] [CrossRef] [PubMed]
[14] Tellegen, A.R., Rudnik-Jansen, I., Beukers, M., Miranda-Bedate, A., Bach, F.C., de Jong, W., et al. (2018) Intradiscal Delivery of Celecoxib-Loaded Microspheres Restores Intervertebral Disc Integrity in a Preclinical Canine Model. Journal of Controlled Release, 286, 439-450. [Google Scholar] [CrossRef] [PubMed]
[15] Krupkova, O., Handa, J., Hlavna, M., Klasen, J., Ospelt, C., Ferguson, S.J., et al. (2016) The Natural Polyphenol Epigallocatechin Gallate Protects Intervertebral Disc Cells from Oxidative Stress. Oxidative Medicine and Cellular Longevity, 2016, Article ID: 7031397. [Google Scholar] [CrossRef] [PubMed]
[16] Hua, W., Li, S., Luo, R., Wu, X., Zhang, Y., Liao, Z., et al. (2020) Icariin Protects Human Nucleus Pulposus Cells from Hydrogen Peroxide-Induced Mitochondria-Mediated Apoptosis by Activating Nuclear Factor Erythroid 2-Related Factor 2. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1866, Article 165575. [Google Scholar] [CrossRef] [PubMed]
[17] Klawitter, M., Quero, L., Klasen, J., Gloess, A.N., Klopprogge, B., Hausmann, O., et al. (2012) Curcuma DMSO Extracts and Curcumin Exhibit an Anti-Inflammatory and Anti-Catabolic Effect on Human Intervertebral Disc Cells, Possibly by Influencing TLR2 Expression and JNK Activity. Journal of Inflammation, 9, Article No. 29. [Google Scholar] [CrossRef] [PubMed]
[18] 张文捷, 张勇, 史明, 等. 淫羊藿苷调控髓核来源间充质干细胞凋亡修复椎间盘退变[J]. 中国组织工程研究, 2023, 27(24): 3803-3809.
[19] Chen, Y., Zheng, Z., Wang, J., Tang, C., Khor, S., Chen, J., et al. (2018) Berberine Suppresses Apoptosis and Extracellular Matrix (ECM) Degradation in Nucleus Pulposus Cells and Ameliorates Disc Degeneration in a Rodent Model. International Journal of Biological Sciences, 14, 682-692. [Google Scholar] [CrossRef] [PubMed]
[20] Deng, X., Wu, W., Liang, H., Huang, D., Jing, D., Zheng, D., et al. (2017) Icariin Prevents Il‐1β‐Induced Apoptosis in Human Nucleus Pulposus via the PI3K/AKT Pathway. Evidence-Based Complementary and Alternative Medicine, 2017, Article ID: 2198323. [Google Scholar] [CrossRef] [PubMed]
[21] Zhang, Z., Wang, C., Lin, J., Jin, H., Wang, K., Yan, Y., et al. (2021) ERRATUM: Therapeutic Potential of Naringin for Intervertebral Disc Degeneration: Involvement of Autophagy against Oxidative Stress-Induced Apoptosis in Nucleus Pulposus Cells. The American Journal of Chinese Medicine, 49, 2049-2052. [Google Scholar] [CrossRef] [PubMed]
[22] 张树文. 基于氧化应激探讨槲皮素防治椎间盘退变的实验研究[D]: [博士学位论文]. 乌鲁木齐: 新疆医科大学, 2021.
[23] Hua, W., Zhang, Y., Wu, X., Kang, L., Tu, J., Zhao, K., et al. (2018) Icariin Attenuates Interleukin-1β-Induced Inflammatory Response in Human Nucleus Pulposus Cells. Current Pharmaceutical Design, 23, 6071-6078. [Google Scholar] [CrossRef] [PubMed]
[24] Wu, P.H., Kim, H.S. and Jang, I. (2020) Intervertebral Disc Diseases PART 2: A Review of the Current Diagnostic and Treatment Strategies for Intervertebral Disc Disease. International Journal of Molecular Sciences, 21, Article 2135. [Google Scholar] [CrossRef] [PubMed]
[25] Dowdell, J., Erwin, M., Choma, T., Vaccaro, A., Iatridis, J. and Cho, S.K. (2017) Intervertebral Disk Degeneration and Repair. Neurosurgery, 80, S46-S54. [Google Scholar] [CrossRef] [PubMed]
[26] Feng, C., Liu, H., Yang, Y., Huang, B. and Zhou, Y. (2015) Growth and Differentiation Factor-5 Contributes to the Structural and Functional Maintenance of the Intervertebral Disc. Cellular Physiology and Biochemistry, 35, 1-16. [Google Scholar] [CrossRef] [PubMed]
[27] Chujo, T., An, H.S., Akeda, K., Miyamoto, K., Muehleman, C., Attawia, M., et al. (2006) Effects of Growth Differentiation Factor-5 on the Intervertebral Disc—In Vitro Bovine Study and in Vivo Rabbit Disc Degeneration Model Study. Spine, 31, 2909-2917. [Google Scholar] [CrossRef] [PubMed]
[28] Li, X., Leo, B.M., Beck, G., Balian, G. and Anderson, G.D. (2004) Collagen and Proteoglycan Abnormalities in the Gdf-5-Deficient Mice and Molecular Changes When Treating Disk Cells with Recombinant Growth Factor. Spine, 29, 2229-2234. [Google Scholar] [CrossRef] [PubMed]
[29] Vadalà, G., Mozetic, P., Rainer, A., Centola, M., Loppini, M., Trombetta, M., et al. (2012) Bioactive Electrospun Scaffold for Annulus Fibrosus Repair and Regeneration. European Spine Journal, 21, 20-26. [Google Scholar] [CrossRef] [PubMed]
[30] Illien-Jünger, S., Pattappa, G., Peroglio, M., Benneker, L.M., Stoddart, M.J., Sakai, D., et al. (2012) Homing of Mesenchymal Stem Cells in Induced Degenerative Intervertebral Discs in a Whole Organ Culture System. Spine, 37, 1865-1873. [Google Scholar] [CrossRef] [PubMed]
[31] Kim, H., Yeom, J.S., Koh, Y., Yeo, J., Kang, K., Kang, Y., et al. (2014) Anti‐Inflammatory Effect of Platelet‐Rich Plasma on Nucleus Pulposus Cells with Response of TNF‐α and IL‐1. Journal of Orthopaedic Research, 32, 551-556. [Google Scholar] [CrossRef] [PubMed]
[32] Gelalis, I.D., Christoforou, G., Charchanti, A., Gkiatas, I., Pakos, E., Papadopoulos, D., et al. (2019) Autologous Platelet-Rich Plasma (PRP) Effect on Intervertebral Disc Restoration: An Experimental Rabbit Model. European Journal of Orthopaedic Surgery & Traumatology, 29, 545-551. [Google Scholar] [CrossRef] [PubMed]
[33] Vasiliadis, E.S., Pneumaticos, S.G., Evangelopoulos, D.S. and Papavassiliou, A.G. (2014) Biologic Treatment of Mild and Moderate Intervertebral Disc Degeneration. Molecular Medicine, 20, 400-409. [Google Scholar] [CrossRef] [PubMed]
[34] Mwale, F., Wang, H.T., Roughley, P., Antoniou, J. and Haglund, L. (2014) Link N and Mesenchymal Stem Cells Can Induce Regeneration of the Early Degenerate Intervertebral Disc. Tissue Engineering Part A, 20, 2942-2949. [Google Scholar] [CrossRef] [PubMed]
[35] Williams, R.J., Tryfonidou, M.A., Snuggs, J.W. and Le Maitre, C.L. (2021) Cell Sources Proposed for Nucleus Pulposus Regeneration. JOR SPINE, 4, e1175. [Google Scholar] [CrossRef] [PubMed]
[36] Ambrosio, L., Schol, J., Ruiz-Fernandez, C., Tamagawa, S., Soma, H., Tilotta, V., et al. (2024) ISSLS PRIZE in Basic Science 2024: Superiority of Nucleus Pulposus Cell-versus Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Attenuating Disc Degeneration and Alleviating Pain. European Spine Journal, 33, 1713-1727. [Google Scholar] [CrossRef] [PubMed]
[37] Elmounedi, N., Bahloul, W. and Keskes, H. (2024) Current Therapeutic Strategies of Intervertebral Disc Regenerative Medicine. Molecular Diagnosis & Therapy, 28, 745-775. [Google Scholar] [CrossRef] [PubMed]
[38] Peredo, A.P., Tsinman, T.K., Bonnevie, E.D., et al. (2024) Developmental Morphogens Direct Human Induced Pluripotent Stem Cells toward an Annulus Fibrosus-Like Cell Phenotype. JOR Spine, 7, e1313.
[39] Sakai, D. and Andersson, G.B.J. (2015) Stem Cell Therapy for Intervertebral Disc Regeneration: Obstacles and Solutions. Nature Reviews Rheumatology, 11, 243-256. [Google Scholar] [CrossRef] [PubMed]
[40] Hohaus, C., Ganey, T.M., Minkus, Y. and Meisel, H.J. (2008) Cell Transplantation in Lumbar Spine Disc Degeneration Disease. European Spine Journal, 17, 492-503. [Google Scholar] [CrossRef] [PubMed]
[41] Watanabe, T., Sakai, D., Yamamoto, Y., Iwashina, T., Serigano, K., Tamura, F., et al. (2010) Human Nucleus Pulposus Cells Significantly Enhanced Biological Properties in a Coculture System with Direct Cell‐to‐Cell Contact with Autologous Mesenchymal Stem Cells. Journal of Orthopaedic Research, 28, 623-630. [Google Scholar] [CrossRef] [PubMed]
[42] Murphy, M.B., Moncivais, K. and Caplan, A.I. (2013) Mesenchymal Stem Cells: Environmentally Responsive Therapeutics for Regenerative Medicine. Experimental & Molecular Medicine, 45, e54-e54. [Google Scholar] [CrossRef] [PubMed]
[43] Pennicooke, B., Moriguchi, Y., Hussain, I., Bonssar, L. and Härtl, R. (2016) Biological Treatment Approaches for Degenerative Disc Disease: A Review of Clinical Trials and Future Directions. Cureus, 8, e892. [Google Scholar] [CrossRef] [PubMed]
[44] Roh, E., Darai, A., Kyung, J., Choi, H., Kwon, S., Bhujel, B., et al. (2021) Genetic Therapy for Intervertebral Disc Degeneration. International Journal of Molecular Sciences, 22, Article 1579. [Google Scholar] [CrossRef] [PubMed]
[45] Zhai, Y., Yang, L., Zheng, W., Wang, Q., Zhu, Z., Han, F., et al. (2023) A Precise Design Strategy for a Cell-Derived Extracellular Matrix Based on Crispr/cas9 for Regulating Neural Stem Cell Function. Biomaterials Science, 11, 6537-6544. [Google Scholar] [CrossRef] [PubMed]
[46] Modi, D., Mohammad, Warsi, M.H., Garg, V., Bhatia, M., Kesharwani, P., et al. (2021) Formulation Development, Optimization, and in Vitro Assessment of Thermoresponsive Ophthalmic Pluronic F127-Chitosan in Situ Tacrolimus Gel. Journal of Biomaterials Science, Polymer Edition, 32, 1678-1702. [Google Scholar] [CrossRef] [PubMed]
[47] Madamsetty, V.S., Tavakol, S., Moghassemi, S., Dadashzadeh, A., Schneible, J.D., Fatemi, I., et al. (2022) Chitosan: A Versatile Bio-Platform for Breast Cancer Theranostics. Journal of Controlled Release, 341, 733-752. [Google Scholar] [CrossRef] [PubMed]
[48] Frapin, L., Clouet, J., Delplace, V., Fusellier, M., Guicheux, J. and Le Visage, C. (2019) Lessons Learned from Intervertebral Disc Pathophysiology to Guide Rational Design of Sequential Delivery Systems for Therapeutic Biological Factors. Advanced Drug Delivery Reviews, 149, 49-71. [Google Scholar] [CrossRef] [PubMed]
[49] Liu, Y., Ren, L. and Wang, Y. (2013) Crosslinked Collagen-Gelatin-Hyaluronic Acid Biomimetic Film for Cornea Tissue Engineering Applications. Materials Science and Engineering: C, 33, 196-201. [Google Scholar] [CrossRef] [PubMed]
[50] Sawamura, K., Ikeda, T., Nagae, M., Okamoto, S., Mikami, Y., Hase, H., et al. (2009) Characterization of in Vivo Effects of Platelet-Rich Plasma and Biodegradable Gelatin Hydrogel Microspheres on Degenerated Intervertebral Discs. Tissue Engineering Part A, 15, 3719-3727. [Google Scholar] [CrossRef] [PubMed]
[51] Chou, A.I. and Nicoll, S.B. (2009) Characterization of Photocrosslinked Alginate Hydrogels for Nucleus Pulposus Cell Encapsulation. Journal of Biomedical Materials Research Part A, 91, 187-194. [Google Scholar] [CrossRef] [PubMed]
[52] Sionkowska, A., Kaczmarek, B., Lewandowska, K., Grabska, S., Pokrywczyńska, M., Kloskowski, T., et al. (2016) 3D Composites Based on the Blends of Chitosan and Collagen with the Addition of Hyaluronic Acid. International Journal of Biological Macromolecules, 89, 442-448. [Google Scholar] [CrossRef] [PubMed]
[53] Dai, T., Tanaka, M., Huang, Y. and Hamblin, M.R. (2011) Chitosan Preparations for Wounds and Burns: Antimicrobial and Wound-Healing Effects. Expert Review of Anti-Infective Therapy, 9, 857-879. [Google Scholar] [CrossRef] [PubMed]
[54] Wismer, N., Grad, S., Fortunato, G., Ferguson, S.J., Alini, M. and Eglin, D. (2014) Biodegradable Electrospun Scaffolds for Annulus Fibrosus Tissue Engineering: Effect of Scaffold Structure and Composition on Annulus Fibrosus Cells in Vitro. Tissue Engineering Part A, 20, 672-682. [Google Scholar] [CrossRef] [PubMed]
[55] Aragon, J., Navascues, N., Mendoza, G. and Irusta, S. (2017) Laser-Treated Electrospun Fibers Loaded with Nano-Hydroxyapatite for Bone Tissue Engineering. International Journal of Pharmaceutics, 525, 112-122. [Google Scholar] [CrossRef] [PubMed]
[56] Francisco, A.T., Hwang, P.Y., Jeong, C.G., Jing, L., Chen, J. and Setton, L.A. (2014) Photocrosslinkable Laminin-Functionalized Polyethylene Glycol Hydrogel for Intervertebral Disc Regeneration. Acta Biomaterialia, 10, 1102-1111. [Google Scholar] [CrossRef] [PubMed]
[57] Henry, N., Clouet, J., Le Visage, C., Weiss, P., Gautron, E., Renard, D., et al. (2017) Silica Nanofibers as a New Drug Delivery System: A Study of the Protein-Silica Interactions. Journal of Materials Chemistry B, 5, 2908-2920. [Google Scholar] [CrossRef] [PubMed]
[58] Vinatier, C., Gauthier, O., Fatimi, A., Merceron, C., Masson, M., Moreau, A., et al. (2009) An Injectable Cellulose‐Based Hydrogel for the Transfer of Autologous Nasal Chondrocytes in Articular Cartilage Defects. Biotechnology and Bioengineering, 102, 1259-1267. [Google Scholar] [CrossRef] [PubMed]
[59] Balmert, S.C. and Little, S.R. (2012) Biomimetic Delivery with Micro‐ and Nanoparticles. Advanced Materials, 24, 3757-3778. [Google Scholar] [CrossRef] [PubMed]
[60] Phromsopha, T. and Baimark, Y. (2014) Preparation of Starch/Gelatin Blend Microparticles by a Water-in-Oil Emulsion Method for Controlled Release Drug Delivery. International Journal of Biomaterials, 2014, Article ID: 829490. [Google Scholar] [CrossRef] [PubMed]
[61] Wilczewska, A.Z., Niemirowicz, K., Markiewicz, K.H. and Car, H. (2012) Nanoparticles as Drug Delivery Systems. Pharmacological Reports, 64, 1020-1037. [Google Scholar] [CrossRef] [PubMed]
[62] Wang, W., Lu, K., Yu, C., Huang, Q. and Du, Y. (2019) Nano-Drug Delivery Systems in Wound Treatment and Skin Regeneration. Journal of Nanobiotechnology, 17, Article No. 82. [Google Scholar] [CrossRef] [PubMed]
[63] Liu, W., Ma, Z., Wang, Y. and Yang, J. (2023) Multiple Nano-Drug Delivery Systems for Intervertebral Disc Degeneration: Current Status and Future Perspectives. Bioactive Materials, 23, 274-299. [Google Scholar] [CrossRef] [PubMed]
[64] van Rijt, S. and Habibovic, P. (2017) Enhancing Regenerative Approaches with Nanoparticles. Journal of The Royal Society Interface, 14, Article 20170093. [Google Scholar] [CrossRef] [PubMed]